Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Citius Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 74 | 1 | 74 | +1 |
| Shares | 24.9M | 154.1K | 26.8M | +2.04M (+8.2%) |
| Value | $17.1M | $105.5K | $20.3M | +$3.33M (+19.6%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 98,693 | $74.7K | 0.00% |
| Deutsche Bank AG | 86,431 | $65.7K | 0.00% |
| LPL Financial LLC | 58,360 | $44.1K | 0.00% |
| Virtu Financial LLC | 51,470 | $39.0K | 0.00% |
| Ground Swell Capital, LLC | 47,537 | $36.0K | 0.13% |
| State Board of Administration of Florida Retirement System | 31,924 | $24.2K | 0.00% |
| TCG Advisory Services, LLC | 30,000 | $22.7K | 0.00% |
| Shared Vision Wealth Group LLC | 10,700 | $8.10K | 0.01% |
| Huntington National Bank | 1,500 | $1.14K | 0.00% |
| American National Bank | 1,000 | $757 | 0.00% |
| Atlantic Edge Private Wealth Management, LLC | 1,000 | $757 | 0.00% |
| REAP Financial Group, LLC | 284 | $214 | 0.00% |
| The PNC Financial Services Group, Inc. | 60 | $45 | 0.00% |
Sold out (12)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Gsa Capital Partners LLP | 198,492 | $136.0K |
| Wealth Advisory Solutions, LLC | 154,130 | $105.5K |
| Allspring Global Investments Holdings, LLC | 111,428 | $76.3K |
| Renaissance Technologies LLC | 89,270 | $61.0K |
| Cambridge Investment Research Advisors, Inc. | 54,600 | $37.0K |
| Commonwealth Equity Services, LLC | 28,254 | $19.0K |
| Pasadena Private Wealth, LLC | 10,965 | $7.50K |
| GTS Securities LLC | 10,068 | $6.89K |
| Williams Jones Wealth Management, LLC. | 10,000 | $6.84K |
| Citadel Advisors LLC | 4,851 | $3.32K |
| GHP Investment Advisors, Inc. | 3,185 | $2.22K |
| WR Wealth Planners, LLC | 100 | $68 |
Not filed for Q4 2023 yet (1)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Key Bridge Compliance, LLC | 154,130 | $105.5K |